Open access
Sep 2026
Haematological toxicity associated with antineoplastic drugs: a pharmacovigilance analysis based on the FDA adverse event reporting system database
A retrospective pharmacovigilance study using FAERS data covering the period from 2004 Q1 to 2025 Q4 reveals a strong signal of haematological toxicity associated with antitumour agents, supporting enhanced routine monitoring to mitigate clinical risks.
Xing-Nong Xu, Lei Ma
· Frontiers in Immunology · 0 citations